Standard Life Aberdeen »

Palvella Therapeutics Inc Ne shares owned by Standard Life Aberdeen

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by Standard Life Aberdeen from 13F filings

Historical chart of Standard Life Aberdeen investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by Standard Life Aberdeen

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.2M 51k 62.69

More positions owned by Standard Life Aberdeen

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Mastercard Incorporated Cl A (MA)
Abbvie (ABBV)
Johnson & Johnson (JNJ)

View all positions for Standard Life Aberdeen

Top funds holding Palvella Therapeutics Inc Ne

BVF
Suvretta Capital Management
Frazier Life Sciences Management
First Light Asset Management
Vanguard Group
BlackRock
Perceptive Advisors
Woodline Partners
Federated Investors
Point72 Asset Management
Nantahala Capital Management
Goldman Sachs Group
Samsara BioCapital
Fred Alger Management
Geode Capital Management

View all funds holding Palvella Therapeutics Inc Ne